MAPK7 and breast cancer: To gain further insights into the oncogenic function of ERK5 in breast cancer, we engineered stable ERK5 knockdown in MDA-MB-231 cells using two distinct shRNAs targeting the 3′UTR or the coding sequence (CDS) of ERK5.